Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Gastroenterology

AGA Releases New Guideline on Endoscopic Eradication Therapy for Barrett’s Esophagus

The American Gastroenterological Association (AGA) has released a new evidence-based Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett’s Esophagus and Related Neoplasia, offering updated recommendations for patients with Barrett’s esophagus, a precursor to esophageal cancer. The guideline emphasizes the importance of endoscopic therapy for removing pre-cancerous cells in patients with high-grade dysplasia, while suggesting a collaborative approach for those with low-grade dysplasia. By focusing on patient-centered care and personalized treatment decisions, the AGA aims to improve outcomes and ensure informed choices for individuals with Barrett’s esophagus.